: Health https://globalnews.ca/?p=11216753 <![CDATA[Thousands of window AC units recalled for mould risk, Health Canada says]]> Fri, 06 Jun 2025 19:50:41 +0000

Share this item via WhatsApp

Tens of thousands of window-mounted air conditioner units are being recalled in Canada as part of a broader North American recall over the risk of mould exposure.

This comes as summer-like temperatures and wildfire smoke spread across many parts of Canada.

The government of Canada recall website says the recall involves several models manufactured by Midea, and sold under brand names including Midea, Comfort Aire, Danby, Frigidaire, Insignia, Keystone, LBG Products, Mr. Cool, Perfect Aire and Sea Breeze specifically designed to fit in windows.

The recall is similar to the notice issued in the United States by the Consumer Product and Safety Commission, which says there are about 1.7 million affected units in the U.S. in addition to nearly 46,000 in Canada.

According to the recall notice, some of these units reportedly are unable to drain pooled water effectively, which can lead to an increased risk of mould growth.

The notice also warns that mould exposure “poses risks of respiratory issues or other infections.”

Click to play video: 'Tenant advocates push for new rules to protect renters from extreme heat'

Tenant advocates push for new rules to protect renters from extreme heat

Warmer temperatures are leading many Canadians to start cranking their air conditioning for relief from the heat, and as wildfires in parts of the Prairies lead to more time spent indoors to avoid exposure to smoke, many could be exposing themselves to mould if they are using AC units under the recall list.

With smoke exposure, some types of air conditioners may protect individuals from the associated risks, but not all types of AC units are effective at filtering out fine particulates found in wildfire smoke.

The manufacturer, Midea, says as of Tuesday, it has received five reports from Canadian customers of mould in their air conditioner units, and says the solution may involve a technician repairing or replacing a drain plug or bubble level.

Affected customers are asked to contact Midea for a free repair or a potential refund where applicable.

&copy 2025 Global News, a division of Corus Entertainment Inc.

]]>
: Health
https://globalnews.ca/?p=11216221 <![CDATA[Ozempic, Wegovy linked to rare cases of eye disorder, EMA says]]> Fri, 06 Jun 2025 12:21:54 +0000

Share this item via WhatsApp

The European Medicines Agency’s safety committee has concluded that the use of Novo Nordisk’s popular weight-loss drug Wegovy and its treatments for type 2 diabetes may cause rare occurrences of a potentially dangerous eye condition.

Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking semaglutide, the active ingredient in Wegovy and Novo’s diabetes drugs Ozempic and Rybelsus, the regulator said on Friday.

The EMA, which started its review in December, said the use of the drugs is linked to about twofold increase in the risk of developing the condition compared to people not taking the medicine.

NAION develops from insufficient blood flow to the optic nerve and causes sudden painless vision loss in one eye. It is the second most common cause of blindness due to optic nerve damage, after glaucoma.

Click to play video: 'GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes'

GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes

Studies have linked semaglutide to NAION in the past. But this is the first time a regulator has made the link.

Trending Now

Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists, which work by helping control blood sugar levels and triggering a feeling of fullness.

A large study of nearly 350,000 diabetics published earlier this year had showed that the risk of developing NAION more than doubled after long-term use of semaglutide, compared to patients taking medicines from other classes.

The EMA said it has reviewed all available data on NAION with semaglutide, including data from non-clinical studies, clinical trials and post-marketing surveillance.

It has recommended the drugmaker to update prescribing information for medicines containing semaglutide to include NAION as a side effect with a frequency of “very rare.”

The U.S. Food and Drug Administration did not immediately respond to a Reuters request for comment.

]]>
: Health
https://globalnews.ca/?p=11214703 <![CDATA[Ontario baby dies after being born prematurely with measles, other complications]]> Thu, 05 Jun 2025 17:17:34 +0000

A premature infant who contracted measles before birth has died in southwestern Ontario, the province’s chief medical officer of health says,

According to Dr. Kieran Moore, the infant’s mother was not vaccinated against measles.

In a statement Thursday, he said while measles may have contributed to both the premature birth and death, the infant also faced other serious medical complications unrelated to the virus.

He offered condolences to the family and thanked the support of health-care providers involved.

“I extend my heartfelt condolences to the family during this incredibly difficult time,” he said. “I also want to thank the dedicated health-care professionals who cared for both the mother and infant with compassion and expertise.”

Dr. Ninh Tran, medical officer of health at Southwestern Public Health, also released a statement on the infant’s death.

“This is devastating news for the community, and we offer our heartfelt thoughts to the family,” Tran said. “We will not be sharing additional details at this time to respect the family’s privacy.”

Click to play video: 'Health Matters: Doctor discusses measles, ticks, sunscreen and more'

Health Matters: Doctor discusses measles, ticks, sunscreen and more

Tran added that the tragedy underscores the serious risk measles poses to pregnant individuals, saying the virus “can cause low birth weight for the baby, preterm birth, and miscarriage.”

Slyvia Jones, deputy premier and health minister, called the news “deeply disturbing” when speaking with reporters at an unrelated news conference Thursday.

“We’ve had a measles vaccine in Canada and around the world for almost five decades, and yet we still have individuals – who for many different reasons – are choosing not to get vaccinated,” Jones said.

“Our multi-million-dollar social media campaign is that reminder to people of the importance, and frankly, the risks of not getting a vaccine. So I hope today’s terrible news really refocuses people’s conversations with their primary care practitioners.”

Click to play video: 'How summer camps are preparing to manage measles this summer'

How summer camps are preparing to manage measles this summer

Trending Now

The infant’s death comes as Ontario continues to battle a measles outbreak that has sickened more than 2,000 people across the province since October 2024.

As of June 3, Ontario has reported 1,729 confirmed and 280 probable cases, including 140 hospitalizations. The majority of those infected were unvaccinated or had unknown immunization status.

Health officials say the virus is particularly dangerous to infants and those who have not been vaccinated. Measles is one of the most contagious diseases in the world and can lead to serious complications such as pneumonia, brain swelling, and premature birth, and, in rare cases, death.

Moore is urging Ontarians, especially those planning to become pregnant, to make sure they are fully immunized.

“Anyone who is unvaccinated is at risk and I urge everyone, but especially those who may become pregnant, to ensure they have received two doses of the MMR vaccine, which will protect both a parent and baby,” he said.

Common symptoms include high fever, rash, Koplik spots, coughing and a runny nose.

Health officials are urging anyone who is unsure of their measles vaccination status or child’s vaccination status, to please contact a health-care provider or local public health unit.

— with files from Aaron D’Andrea

&copy 2025 Global News, a division of Corus Entertainment Inc.

]]>
: Health
https://globalnews.ca/?p=11214214 <![CDATA[Some Seasonale birth control pills recalled due to extra placebos]]> Thu, 05 Jun 2025 14:42:46 +0000

Share this item via WhatsApp

Two lots of Seasonale birth control medication are being recalled by the manufacturer after it received a complaint that they contained extra placebo pills.

Teva Canada Ltd. said it received a complaint that a package contained an extra row of placebos when there should only be one row of white pills.

“Taking placebo pills instead of active (pink) pills may reduce the effectiveness of the product and could lead to an unintended pregnancy,” the recall notice posted by Health Canada says.

Seasonale pills come packaged in a dispenser that contains a 13-week, or 91-day, supply divided into three blister cards, each on its own tray.

The first two trays each hold 28 active pills, while the third tray has 35 pills — 28 pink pills and seven white placebo pills.

The two lots in question, however, have an extra row of white placebo pills on the second tray.

A package of Seasonale birth control pills is pictured with an extra row of placebo pills. This issue prompted a recall by Health Canada.
A package of Seasonale birth control pills is pictured with an extra row of placebo pills. This issue prompted a recall by Health Canada. Health Canada

The lot numbers being recalled are 100059661 with an expiry date of Jan. 31, 2026, and 100069150 with a Sept. 30, 2026 expiry.

Trending Now

According to the Health Canada recall notice, Seasonale should be taken daily unless directed otherwise by the person who prescribed the medication.

Instructions that come with the product say that taking the pills in the proper order is important to prevent pregnancy, and taking a placebo out of order could lead to unplanned pregnancy, as well as other side effects, including spotting and irregular bleeding.

Those using the pills are also advised to check the package and if it contains any placebos in the first two trays to not take them and return them to the pharmacy for a replacement or alternative product.

“If you cannot get to a pharmacy right away, take the next active (pink) pill in the proper order as noted in the instructions until you are able to contact your pharmacist and obtain a replacement or alternative product,” the Health Canada notice says.

Anyone who took a placebo instead of active pill from tray one or two, or if you’re unsure, should use another method of non-hormonal backup contraception, such as condoms, and consult your health-care professional.

&copy 2025 Global News, a division of Corus Entertainment Inc.

]]>
: Health
https://globalnews.ca/?p=11214184 <![CDATA[U.S. hospitals no longer required to perform emergency abortions]]> Thu, 05 Jun 2025 12:54:14 +0000

The Trump administration announced on Tuesday that it would revoke guidance to the nation’s hospitals that directed them to provide emergency abortions for women when they are necessary to stabilize their medical condition.

That guidance was issued to hospitals in 2022, weeks after the U.S. Supreme Court upended national abortion rights in the U.S. It was an effort by the Biden administration to preserve abortion access for extreme cases in which women were experiencing medical emergencies and needed an abortion to prevent organ loss or severe hemorrhaging, among other serious complications.

The Biden administration had argued that hospitals — including ones in states with near-total bans — needed to provide emergency abortions under the Emergency Medical Treatment and Active Labor Act. That law requires emergency rooms that receive Medicare dollars to provide an exam and stabilizing treatment for all patients. Nearly all emergency rooms in the U.S. rely on Medicare funds.

The Trump administration announced on Tuesday that it would no longer enforce that policy.

The move prompted concerns from some doctors and abortion rights advocates that women will not get emergency abortions in states with strict bans.

Click to play video: 'Carney says he supports a woman’s right to choose abortion'

Carney says he supports a woman’s right to choose abortion

“The Trump Administration would rather women die in emergency rooms than receive life-saving abortions,” Nancy Northup, president and CEO of the Center for Reproductive Rights, said in a statement. “In pulling back guidance, this administration is feeding the fear and confusion that already exists at hospitals in every state where abortion is banned. Hospitals need more guidance, not less, to stop them from turning away patients experiencing pregnancy crises.”

Anti-abortion advocates, meanwhile, praised the announcement. Marjorie Dannenfelser, president of SBA Pro-Life America, said in a statement that the Biden-era policy had been a way to expand abortion access in states where it was banned.

“Democrats have created confusion on this fact to justify their extremely unpopular agenda for all-trimester abortion,” she said. “In situations where every minute counts, their lies lead to delayed care and put women in needless, unacceptable danger.”

An Associated Press investigation last year found that, even with the Biden administration’s guidance, dozens of pregnant women were being turned away from emergency rooms, including some who needed emergency abortions.

Trending Now

Click to play video: 'Health Matters: Abortion rights advocates win in 7 states'

Health Matters: Abortion rights advocates win in 7 states

The Centers for Medicare and Medicaid Services, which provides oversight of hospitals, said in a statement that it will continue to enforce the federal law that, “including for identified emergency medical conditions that place the health of a pregnant woman or her unborn child in serious jeopardy.”

But CMS added that it would also “rectify any perceived legal confusion and instability created by the former administration’s actions.”

The Biden administration sued Idaho over its abortion law that initially only allowed abortions to save the life of the mother. The federal government had argued before the U.S. Supreme Court last year that Idaho’s law was in conflict with the federal law, which requires stabilizing treatment that prevents a patient’s condition from worsening.

The U.S. Supreme Court issued a procedural ruling in the case last year that left key questions unanswered about whether doctors in abortion-ban states can terminate pregnancies when a woman is at risk of serious infection, organ loss or hemorrhage.

&copy 2025 The Canadian Press

]]>
: Health
https://globalnews.ca/?p=11213382 <![CDATA[Do you know about the health damage long-term wildfire smoke exposure can cause?]]> Wed, 04 Jun 2025 22:38:49 +0000 : Health https://globalnews.ca/?p=11211447 <![CDATA[Infant formula is under health review in the U.S. What parents should know]]> Tue, 03 Jun 2025 22:20:58 +0000 : Health https://globalnews.ca/?p=11211168 <![CDATA[Trump admin revokes guidance for hospitals to provide emergency abortions]]> Tue, 03 Jun 2025 20:52:09 +0000 : Health https://globalnews.ca/?p=11210887 <![CDATA[Health minister won’t intervene on forcing addictions treatment]]> Tue, 03 Jun 2025 18:49:34 +0000 : Health https://globalnews.ca/?p=11210339 <![CDATA[Weight-loss drug Wegovy use is up 50% among U.S. teens, study shows]]> Tue, 03 Jun 2025 15:27:36 +0000 : Health